Jim Reddoch ^Investor

Jim Reddoch is an experienced executive with a background in biotech research and investments. He has held leadership roles at Royalty Pharma, FBR Capital Markets, and Yale Ventures. Jim is currently serving as EVP Investments & CSO at Royalty Pharma, where he sources investments, conducts diligence, and manages a team. He is also a board member at Avillion, The Leukemia & Lymphoma Society, and Life Science Cares New York, focusing on drug development, health, and poverty alleviation. Jim's achievements include leading high-profile healthcare research teams and contributing to strategic philanthropic initiatives in the life science sector. Connect with him on LinkedIn for insights on drug development and investment strategies.